RhinosinusitisEarly Phase 1NCT02636790
Early Versus Late Surgical Wait Times
A Early Phase 1 study testing Surgery wait time in people with Rhinosinusitis, run by University of British Columbia at 2 sites in Canada.
Trial summary
The sinus surgical wait list in British Columbia continues to grow. The current wait list is beyond what is acceptable by the province's standard; however, this is not likely to improve given the budget constraints of the health care system. Read more about this study
- Who is it for?
- Ages 19 years and older
- Conditions the study is for
- Rhinosinusitis
- What is being tested?
- Surgery wait time
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 2 sitesCanada
- Study dates
- Sep 2018to Jun 2020
- Phase
- Early Phase 1
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients diagnosed with CRS based on 2 major symptoms (congestion, facial pain, nasal obstruction, nasal discharge, decreased sense of smell) and evidence of sino-nasal inflammation on CT scan and nasal endoscopy. Symptoms must also be present for >12 weeks.
Who cannot join
- History of or requiring surgery for a sino-nasal tumour
Trial locations and contacts
2 sites in 1 country.
Canada2 sites
UBC - Department of Surgery Division of Otolaryngology - Head and Neck Surgery
Vancouver, British Columbia, V5Z 1M9
Arif Janjua, MD, 604-875-8296, dr.janjua.office@gmail.com
Javier Ospina, MD, 604-715-8276, jospinadiaz@gmail.com
UBC
Vancouver, British Columbia, V6H 0A5
Vancouver G Hospital, MD, 6048758296, janjua.arif@gmail.com
About this study
Official title: Is Prioritization of the Sinus Surgical Waitlist Required?
The sinus surgical wait list in British Columbia continues to grow. The current wait list is beyond what is acceptable by the province's standard; however, this is not likely to improve given the budget constraints of the health care system. The outcome of having patients to wait longer than medically reasonable for surgery, not only affects the patients' quality of life but presents financial difficulties, both directly to the patient, the healthcare system and the economy as a whole. Therefore, the investigators need to determine which patients need to be prioritized for surgery. The investigators will follow two groups of patients - one group from Stanford University who get surgery always before 8 weeks and compare them to patients on the VGH wait list which is often more than one year.
Read the detailed description
Introduction Five percent of Canadians suffer from Chronic Rhinosinusitis (CRS) based on a national survey.1 CRS sufferers have debilitating facial pain, nasal congestion, nasal discharge and poor sense of smell. Relative to other chronic diseases, the quality of life of patients suffering with CRS is comparable to diseases such as congestive heart failure, chronic obstructive pulmonary disease, angina and back pain.3 Currently, CRS patients in Vancouver, British Columbia wait just over a year for surgery. British Columbia's (BC) health care policy recommends that CRS patients waiting for surgery be done in twelve weeks. It is well recognized that patients who wait longer than medically reasonable for surgery result in an excess costs, both directly to the patient, the healthcare system and the economy as a whole.5 Unfortunately, no studies done in Canada have illustrated the direct and indirect costs associated with CRS annually.
Patients' waiting time for elective sinus surgery in BC has come under public scrutiny in recent years. As a result, policy-makers are keen to address this waitlist issue.4 The government has identified sinus surgery as an elective day procedure that requires the Patient Focused Fund (PFF) to increase volume and address its disproportionately large waitlist. This likely has resulted in savings to VCH patients and the BC Health Ministry that would not have occurred had the PFF not been initiated. However, policy-makers must explore other innovate ways to supplement the PFF to provide further savings to VCH patients and the BC health care system.
An approach that has been adopted by other specialities such as orthopaedics, ophthalmology, and radiology is the use of a validated tool to prioritize waitlists.6-8 There are no validated tools published for prioritizing sinus surgery waitlists. The Canadian Institutes of Health Research provided funding to establish the Western Canada Waiting List Project (WCWL) to "improve the fairness of the health care system so that Canadians' access to appropriate and effective medical services is prioritized on the basis of need and potential benefit."9 Despite the work done by the WCWL being limited to five clinical areas (cataract surgery; general surgery procedures; hip and knee replacement; magnetic resonance imaging (MRI) scanning, and children's mental health), the methodology utilized in establishing their prioritization tool can be used to establish one for the sinus surgery waitlist;10 The impact of chronic diseases, including CRS, varies among patients11; therefore, prioritizing patients based on clinical measurements and cost-effectiveness from an individual and healthcare system perspective would be a novel approach to addressing waitlists for sinus surgery. Currently, VCH CRS patients are treated on a first come, first served basis. Despite this being the most transparent way of ordering the waitlist, the investigators feel VCH CRS patients need a waitlist system that promotes wellness and ensures care that focuses on quality - this can be achieved with a prioritized waitlist based on quality of life improvement and decreased healthcare expenditure.
Prior to establishing a validated tool for the prioritization of sinus surgery waitlists, one must first determine if VCH patients and the BC health care system would benefit from prioritized surgery. Providing a solution to this question requires moderate amount of resources and would take several of years to complete. The investigators propose a feasibility study coupled with an economic evaluation to determine if the disproportionately long wait list faced by CRS patients can be optimized and thus improve patient outcomes.
Current State of Knowledge Researchers must determine if CRS patients and the BC health care system would benefit from a prioritized waitlist for sinus surgery. It is accepted that sinus surgery compared to medical therapy improves the quality of life of CRS patients.12-14 However, to determine whether VCH CRS patients would benefit from a prioritized waitlist, the investigators must answer the following questions. If patients were to have surgery sooner: 1) how does their quality of life change with time compared to those on the waitlist? 2) do they experience a reduction in out of pocket costs?; 3) does the healthcare system experience a decrease in healthcare expenditure? and 4) is there are a subgroup of patients who would particularly benefit more than others from early surgical intervention? Providing this information is vital in determining if a prioritized waitlist would be beneficial for sinus surgery.
Patient Recruitment:
Recruitment of patients will occur at two centres. Patients classified as "prioritized surgery" will be recruited from Stanford Sinus Centre, Palo Alto, California. Patients classified as "standard waitlist" patients will be recruited from Vancouver General Hospital, Vancouver, Canada. The PI will identify consecutive patients that fit the inclusion/exclusion criteria and are being enrolled for sinus surgery. The study coordinator (or designate) will discuss the study with the identified patients and allow patients up to 7 days to provide consent.
On the day of consent:
A diagnosis of the patient's medical health will be conducted by the study investigators and a Lund-Mackay and Lund-Kennedy score systems will be used to assess the patient's chronic rhinosinusitis. Additionally, the state of the rhinosinusitis will be evaluated on the day of consent and on every subsequent follow-up visit. A questionnaire relating to demographics will be obtained as well (Appendix D).
Approach to Each Aim:
Aim 1: The investigators will compare how the quality of life of CRS patients change with time when prioritized to early surgical intervention compared to those on the standard waitlist.
All CRS patients participating in the study will fill in a disease-specific health related quality of life instrument for CRS patients known as the Sinonasal Outcome Test (SNOT-22) and two generic assessment of health status known as the WPAI-SHP and EQ-5D (Appendix A) every 2 months for 1 year.
The study coordinator (or designate) will contact patients every 2 months via email and provide them with a secure link to fill in each questionnaire. When questionnaires are complete, they will be saved directly into their medical records.
Rationale for Questionnaires: The Sinonasal Outcome Test (SNOT-22) is a validated questionnaire.16 SNOT-22 is a disease-specific health-related quality of life instrument in CRS patients. The EQ-5D has 5 questions addressing: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The Work Productivity and Activity - Specific Health Problem (WPAI:SHP) is a validated instrument to evaluate impairment of daily activities and work productivity associated with a specific health problem (Chronic Rhinosinusitis). The work productivity impairment domain is a sum of impairment in work productivity due to absenteeism and due to decreased productivity while working (presenteeism); this domain is assessed only in employed patients. The activity impairment domain is assessed in all participants regardless of their employment status and represents impairment in daily activities other than work.18 The investigators would prefer to use an easy to administer generic health measure like the EQ-5D compared to the WPAI-SHP, but during the feasibility stage, the investigators will administer both questionnaires and at the completion of the study determine the most appropriate questionnaire for this study.
Aim 2: To determine if patients prioritized to early surgical intervention experience a reduction in out of pocket costs compared to patients on the standard waitlist.
All CRS patients participating in the study will fill in a questionnaire regarding personal costs incurred over 1 year. To ensure the most accurate costs are tabulated, patients will fill in this questionnaire every two months (Appendix B).
The study coordinator (or designate) will contact patients every two months via email and provide them with a secure link to fill in questions from Appendix B similar to Aim 1. The study coordinator (or designate) will follow the same protocol of contacting the patient if the questionnaire is not filled in a timely manner. Patients can also complete this Aim on a hard copy similar to Aim 1.
To ensure the investigators were inclusive of all the cost incurred by CRS patients, a sample population of 30 VCH CRS patients were surveyed. Moreover, a panel that included multiple Rhinologists and a Health Economist established questions that were pertinent to costs incurred by the patient that may have been overlooked by the sample population. This process ensures that the most accurate estimate of personal costs incurred by CRS patients while waiting for surgery and those prioritized to early surgery. (Appendix B) Aim 3: The investigators will determine if the Canadian health care system experiences a decrease in healthcare expenditure if CRS patients are enlisted for early surgical intervention versus patients on the standard waitlist.
When VCH CRS patients are addressing Aim 2, they will also have additional questions that pertain to costs incurred by the health care system (Appendix B). The PI will fill in a questionnaire regarding costs incurred by the health care system for 1 year for each patient when there is a believed cost to the public system that is atypical compared with expected costs (Appendix C). During each clinical for each patient, the PI will tabulate the costs incurred during the patient's clinical visit.
Like in Aim 2, a panel consisting of multiple Rhinologists established Appendix C. Moreover, during three clinical days by the PI, extra costs incurred by the VCH health care system were noted and included into Appendix C.
Aim 4: The investigators will determine if there is a subgroup of CRS patients who would benefit from early surgical intervention.
Stratification of VCH CRS patients and determining if patients benefited from early surgical intervention will be established through demographic information, clinical findings and comparison of outcomes obtained in Aims 1-3. Demographic information will be obtained on the day consent is obtained (Appendix D). The PI will also complete a standardized consultation/follow-up form for each visit to report clinical findings.
The PI will also complete a standardized consultation/follow-up form, including an evaluation of healing subsequent to nasal surgery based on the Lund-Kennedy score, for each visit to document clinical findings.
Analysis:
Pre-Study Sample Size Calculation - Sample size for comparison on average difference in SNOT-22 scores between two equally sized group over time followed the Diggle et al formula.19 Based on an effect size of 9 points15 between the early intervention and standard waitlist patients, type 1 probability of 5% (α = 0.05), a type 2 probability of 20% (β = 0.20), standard deviation of 20 from pre- and post surgical values15 and 6 measurements of SNOT-22 over 12 months, the assumed correlation (p) will range from 0.75 and 1.00 if 124 to 156 patients are recruited, therefore allowing for a conservative estimate of 10% drop-out.
Post-Study Completion - Aim 1 will be analyzed using 2-sample t-test. The investigators will conduct a cost-utility analysis to evaluate Aims 2 and 3. the investigators assume the cost of surgery for the early intervention group will be the same as those who will receive in it on the standard waitlist; therefore, this cost will be removed from the early intervention group. The economic model will evaluate costs and utilities (measured by EQ-5D and WPAI-SHP) and calculate incremental cost-effectiveness ratios (ICERs). The time horizon for this evaluation will be 1 year. No other discounting of costs or utilities is required given this time horizon. Uncertainty around the ICERs will be quantified using bootstrapping. Aim 4 will be analyzed using linear regression models. The best-fit model will provide insight to sub-population of CRS patients who would benefit from early surgical intervention.
- Conditions
- Rhinosinusitis
- Being tested
- Surgery wait time
- Medical subject headings
- Rhinosinusitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Surgery wait timeProcedure or surgery
VCH CRS patients need a waitlist system that promotes wellness and ensures care that focuses on quality - this can be achieved with a prioritized waitlist based on quality of life improvement and decreased healthcare expenditure.
| Study group | Role | What they receive |
|---|---|---|
| Surgery wait time (< 8 weeks) | Active comparator | Outcomes of patients with sinus surgery of less than 8 weeks. Receives: Procedure: Surgery wait time |
| Surgery wait time (> 1 year) | Active comparator | Outcomes of patients with sinus surgery of more than 1 year. Receives: Procedure: Surgery wait time |
What is being measured
The primary outcome is the main question the study is designed to answer.
Questionnaire relating to demographics.
Patient demographic information to be completed once after surgery to determine if there is a distinct group of chronic Rhinosinusitis patients who would benefit from early surgical intervention.
Measured: 30 min to complete questionnaire (once)
Change relating to personal costs over 1 year following surgery.
Personal costs related to surgical wait times.
Measured: 30 min to complete questionnaire, every two months for 1 year (post-surgery).
Change to the quality of life over 1 year following surgery based on the WPAI-SHP questionnaire.
The questionnaire WPAI-SHP relates to quality of life after surgery. The Work Productivity and Activity - Specific Health Problem (WPAI:SHP) is a validated instrument to evaluate impairment of daily activities and work productivity associated with a specific health problem (Chronic Rhinosinusitis).
Measured: 10 min to complete questionnaire, every two months for 1 year (post-surgery).
Change to the quality of life over 1 year following surgery based on the SNOT-22 questionnaire.
The questionnaire SNOT-22 relates to quality of life after surgery. SNOT-22 is a disease-specific health-related quality of life instrument in CRS patients.
Measured: 10 min to complete questionnaire, every two months for 1 year (post-surgery).
Change to the quality of life over 1 year following surgery based on the EQ5-D questionnaire.
The questionnaire EQ5-D relates to quality of life after surgery. The EQ-5D has 5 questions addressing: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
Measured: 10 min to complete questionnaire, every two months for 1 year (post-surgery).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Dec 2015 (estimated)
- Study startSep 2018 (estimated)
- Primary completionDec 2019 (estimated)
- Study completionJun 2020 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (19)Papers the sponsor has linked to this study.
- Other trials for RhinosinusitisStudies of the same condition, open and under way.
- More trials run by University of British ColumbiaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Early Phase 1
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 20 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of British Columbia
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Arif Janjua, University of British Columbia
- Investigators
- Arif Janjua, MD, Principal investigator, UBC
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02636790
- Sponsor's protocol ID
- H15-02020
- Status last verified
- May 2018
- First submitted
- 3 Dec 2015
- Last updated
- 8 May 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Chen Y, Dales R, Lin M. The epidemiology of chronic rhinosinusitis in Canadians. Laryngoscope. 2003 Jul;113(7):1199-205. doi: 10.1097/00005537-200307000-00016.
PubMed 12838019Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Adv Data. 2002 Jun 5;(328):1-32.
PubMed 12661586Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg. 1995 Jul;113(1):104-9. doi: 10.1016/S0194-59989570152-4.
PubMed 7603703Mickleburgh, R. (2013, January 18). Ministers says BC wait lists too long. The Globe and Mail, Health Care, http://m.theglobeandmail.com/news/british-columbia/minister-says-bc-wait-lists-too-long/article7508904/?service=mobile (accessed on January 30, 2013).
The economic cost of wait times in Canada. Retrieved from www.cma.ca/multimedia/CMA/Content.../EconomicReport.pdf (accessed on February 2, 2013).
Conner-Spady BL, Sanmugasunderam S, Courtright P, Mildon D, McGurran JJ, Noseworthy TW; Steering Committee of the Western Canada Waiting List Project. The prioritization of patients on waiting lists for cataract surgery: validation of the Western Canada waiting list project cataract priority criteria tool. Ophthalmic Epidemiol. 2005 Apr;12(2):81-90. doi: 10.1080/09286580590932770.
PubMed 16019691Conner-Spady B, Estey A, Arnett G, Ness K, McGurran J, Bear R, Noseworthy T; Steering Committee of the Western Canada Waiting List Project. Prioritization of patients on waiting lists for hip and knee replacement: validation of a priority criteria tool. Int J Technol Assess Health Care. 2004 Fall;20(4):509-15. doi: 10.1017/s0266462304001436.
PubMed 15609803Hadorn DC; Steering Committee of the Western Canada Waiting List Project. Developing priority criteria for magnetic resonance imaging: results from the Western Canada Waiting List Project. Can Assoc Radiol J. 2002 Oct;53(4):210-8.
PubMed 12391927Noseworthy TW, McGurran JJ, Hadorn DC; Steering Committee of the Western Canada Waiting List Project. Waiting for scheduled services in Canada: development of priority-setting scoring systems. J Eval Clin Pract. 2003 Feb;9(1):23-31. doi: 10.1046/j.1365-2753.2003.00377.x.
PubMed 12558699Ben-Shlomo Y, Kuh D. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol. 2002 Apr;31(2):285-93. No abstract available.
PubMed 11980781Western Canada Waiting List Investigators .(2013). Retrieved on February 2, 2013 from http://www.wcwl.ca/.
Damm M, Quante G, Jungehuelsing M, Stennert E. Impact of functional endoscopic sinus surgery on symptoms and quality of life in chronic rhinosinusitis. Laryngoscope. 2002 Feb;112(2):310-5. doi: 10.1097/00005537-200202000-00020.
PubMed 11889389Smith TL, Kern R, Palmer JN, Schlosser R, Chandra RK, Chiu AG, Conley D, Mace JC, Fu RF, Stankiewicz J. Medical therapy vs surgery for chronic rhinosinusitis: a prospective, multi-institutional study with 1-year follow-up. Int Forum Allergy Rhinol. 2013 Jan;3(1):4-9. doi: 10.1002/alr.21065. Epub 2012 Jun 26.
PubMed 22736422Smith TL, Mendolia-Loffredo S, Loehrl TA, Sparapani R, Laud PW, Nattinger AB. Predictive factors and outcomes in endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope. 2005 Dec;115(12):2199-205. doi: 10.1097/01.mlg.0000182825.82910.80.
PubMed 16369166Bhattacharyya N, Orlandi RR, Grebner J, Martinson M. Cost burden of chronic rhinosinusitis: a claims-based study. Otolaryngol Head Neck Surg. 2011 Mar;144(3):440-5. doi: 10.1177/0194599810391852. Epub 2011 Feb 3.
PubMed 21493210
Study at a glance
From the registry record, last updated by the sponsor on 8 May 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Is Prioritization of the Sinus Surgical Waitlist Required?
- ClinicalTrials.gov ID
- NCT02636790
- Acronym / sponsor ID
- H15-02020
- Conditions
- Rhinosinusitis
- Phase
- Early Phase 1
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 20 participants (estimated)
- Lead sponsor
- University of British ColumbiaUniversity, hospital or other
- Study start
- Sep 2018 (estimated)
- Primary completion
- Dec 2019 (estimated)
- Study completion
- Jun 2020 (estimated)
- First posted
- 22 Dec 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The sinus surgical wait list in British Columbia continues to grow. The current wait list is beyond what is acceptable by the province's standard; however, this is not likely to improve given the budget constraints of the health care system. The outcome of having patients to wait longer than medically reasonable for surgery, not only affects the patients' quality of life but presents financial difficulties, both directly to the patient, the healthcare system and the economy as a whole. Therefore, the investigators need to determine which patients need to be prioritized for surgery. The investigators will follow two groups of patients - one group from Stanford University who get surgery always before 8 weeks and compare them to patients on the VGH wait list which is often more than one year.
Detailed description
Introduction Five percent of Canadians suffer from Chronic Rhinosinusitis (CRS) based on a national survey.1 CRS sufferers have debilitating facial pain, nasal congestion, nasal discharge and poor sense of smell. Relative to other chronic diseases, the quality of life of patients suffering with CRS is comparable to diseases such as congestive heart failure, chronic obstructive pulmonary disease, angina and back pain.3 Currently, CRS patients in Vancouver, British Columbia wait just over a year for surgery. British Columbia's (BC) health care policy recommends that CRS patients waiting for surgery be done in twelve weeks. It is well recognized that patients who wait longer than medically reasonable for surgery result in an excess costs, both directly to the patient, the healthcare system and the economy as a whole.5 Unfortunately, no studies done in Canada have illustrated the direct and indirect costs associated with CRS annually.
Patients' waiting time for elective sinus surgery in BC has come under public scrutiny in recent years. As a result, policy-makers are keen to address this waitlist issue.4 The government has identified sinus surgery as an elective day procedure that requires the Patient Focused Fund (PFF) to increase volume and address its disproportionately large waitlist. This likely has resulted in savings to VCH patients and the BC Health Ministry that would not have occurred had the PFF not been initiated. However, policy-makers must explore other innovate ways to supplement the PFF to provide further savings to VCH patients and the BC health care system.
An approach that has been adopted by other specialities such as orthopaedics, ophthalmology, and radiology is the use of a validated tool to prioritize waitlists.6-8 There are no validated tools published for prioritizing sinus surgery waitlists. The Canadian Institutes of Health Research provided funding to establish the Western Canada Waiting List Project (WCWL) to "improve the fairness of the health care system so that Canadians' access to appropriate and effective medical services is prioritized on the basis of need and potential benefit."9 Despite the work done by the WCWL being limited to five clinical areas (cataract surgery; general surgery procedures; hip and knee replacement; magnetic resonance imaging (MRI) scanning, and children's mental health), the methodology utilized in establishing their prioritization tool can be used to establish one for the sinus surgery waitlist;10 The impact of chronic diseases, including CRS, varies among patients11; therefore, prioritizing patients based on clinical measurements and cost-effectiveness from an individual and healthcare system perspective would be a novel approach to addressing waitlists for sinus surgery. Currently, VCH CRS patients are treated on a first come, first served basis. Despite this being the most transparent way of ordering the waitlist, the investigators feel VCH CRS patients need a waitlist system that promotes wellness and ensures care that focuses on quality - this can be achieved with a prioritized waitlist based on quality of life improvement and decreased healthcare expenditure.
Prior to establishing a validated tool for the prioritization of sinus surgery waitlists, one must first determine if VCH patients and the BC health care system would benefit from prioritized surgery. Providing a solution to this question requires moderate amount of resources and would take several of years to complete. The investigators propose a feasibility study coupled with an economic evaluation to determine if the disproportionately long wait list faced by CRS patients can be optimized and thus improve patient outcomes.
Current State of Knowledge Researchers must determine if CRS patients and the BC health care system would benefit from a prioritized waitlist for sinus surgery. It is accepted that sinus surgery compared to medical therapy improves the quality of life of CRS patients.12-14 However, to determine whether VCH CRS patients would benefit from a prioritized waitlist, the investigators must answer the following questions. If patients were to have surgery sooner: 1) how does their quality of life change with time compared to those on the waitlist? 2) do they experience a reduction in out of pocket costs?; 3) does the healthcare system experience a decrease in healthcare expenditure? and 4) is there are a subgroup of patients who would particularly benefit more than others from early surgical intervention? Providing this information is vital in determining if a prioritized waitlist would be beneficial for sinus surgery.
Patient Recruitment:
Recruitment of patients will occur at two centres. Patients classified as "prioritized surgery" will be recruited from Stanford Sinus Centre, Palo Alto, California. Patients classified as "standard waitlist" patients will be recruited from Vancouver General Hospital, Vancouver, Canada. The PI will identify consecutive patients that fit the inclusion/exclusion criteria and are being enrolled for sinus surgery. The study coordinator (or designate) will discuss the study with the identified patients and allow patients up to 7 days to provide consent.
On the day of consent:
A diagnosis of the patient's medical health will be conducted by the study investigators and a Lund-Mackay and Lund-Kennedy score systems will be used to assess the patient's chronic rhinosinusitis. Additionally, the state of the rhinosinusitis will be evaluated on the day of consent and on every subsequent follow-up visit. A questionnaire relating to demographics will be obtained as well (Appendix D).
Approach to Each Aim:
Aim 1: The investigators will compare how the quality of life of CRS patients change with time when prioritized to early surgical intervention compared to those on the standard waitlist.
All CRS patients participating in the study will fill in a disease-specific health related quality of life instrument for CRS patients known as the Sinonasal Outcome Test (SNOT-22) and two generic assessment of health status known as the WPAI-SHP and EQ-5D (Appendix A) every 2 months for 1 year.
The study coordinator (or designate) will contact patients every 2 months via email and provide them with a secure link to fill in each questionnaire. When questionnaires are complete, they will be saved directly into their medical records.
Rationale for Questionnaires: The Sinonasal Outcome Test (SNOT-22) is a validated questionnaire.16 SNOT-22 is a disease-specific health-related quality of life instrument in CRS patients. The EQ-5D has 5 questions addressing: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The Work Productivity and Activity - Specific Health Problem (WPAI:SHP) is a validated instrument to evaluate impairment of daily activities and work productivity associated with a specific health problem (Chronic Rhinosinusitis). The work productivity impairment domain is a sum of impairment in work productivity due to absenteeism and due to decreased productivity while working (presenteeism); this domain is assessed only in employed patients. The activity impairment domain is assessed in all participants regardless of their employment status and represents impairment in daily activities other than work.18 The investigators would prefer to use an easy to administer generic health measure like the EQ-5D compared to the WPAI-SHP, but during the feasibility stage, the investigators will administer both questionnaires and at the completion of the study determine the most appropriate questionnaire for this study.
Aim 2: To determine if patients prioritized to early surgical intervention experience a reduction in out of pocket costs compared to patients on the standard waitlist.
All CRS patients participating in the study will fill in a questionnaire regarding personal costs incurred over 1 year. To ensure the most accurate costs are tabulated, patients will fill in this questionnaire every two months (Appendix B).
The study coordinator (or designate) will contact patients every two months via email and provide them with a secure link to fill in questions from Appendix B similar to Aim 1. The study coordinator (or designate) will follow the same protocol of contacting the patient if the questionnaire is not filled in a timely manner. Patients can also complete this Aim on a hard copy similar to Aim 1.
To ensure the investigators were inclusive of all the cost incurred by CRS patients, a sample population of 30 VCH CRS patients were surveyed. Moreover, a panel that included multiple Rhinologists and a Health Economist established questions that were pertinent to costs incurred by the patient that may have been overlooked by the sample population. This process ensures that the most accurate estimate of personal costs incurred by CRS patients while waiting for surgery and those prioritized to early surgery. (Appendix B) Aim 3: The investigators will determine if the Canadian health care system experiences a decrease in healthcare expenditure if CRS patients are enlisted for early surgical intervention versus patients on the standard waitlist.
When VCH CRS patients are addressing Aim 2, they will also have additional questions that pertain to costs incurred by the health care system (Appendix B). The PI will fill in a questionnaire regarding costs incurred by the health care system for 1 year for each patient when there is a believed cost to the public system that is atypical compared with expected costs (Appendix C). During each clinical for each patient, the PI will tabulate the costs incurred during the patient's clinical visit.
Like in Aim 2, a panel consisting of multiple Rhinologists established Appendix C. Moreover, during three clinical days by the PI, extra costs incurred by the VCH health care system were noted and included into Appendix C.
Aim 4: The investigators will determine if there is a subgroup of CRS patients who would benefit from early surgical intervention.
Stratification of VCH CRS patients and determining if patients benefited from early surgical intervention will be established through demographic information, clinical findings and comparison of outcomes obtained in Aims 1-3. Demographic information will be obtained on the day consent is obtained (Appendix D). The PI will also complete a standardized consultation/follow-up form for each visit to report clinical findings.
The PI will also complete a standardized consultation/follow-up form, including an evaluation of healing subsequent to nasal surgery based on the Lund-Kennedy score, for each visit to document clinical findings.
Analysis:
Pre-Study Sample Size Calculation - Sample size for comparison on average difference in SNOT-22 scores between two equally sized group over time followed the Diggle et al formula.19 Based on an effect size of 9 points15 between the early intervention and standard waitlist patients, type 1 probability of 5% (α = 0.05), a type 2 probability of 20% (β = 0.20), standard deviation of 20 from pre- and post surgical values15 and 6 measurements of SNOT-22 over 12 months, the assumed correlation (p) will range from 0.75 and 1.00 if 124 to 156 patients are recruited, therefore allowing for a conservative estimate of 10% drop-out.
Post-Study Completion - Aim 1 will be analyzed using 2-sample t-test. The investigators will conduct a cost-utility analysis to evaluate Aims 2 and 3. the investigators assume the cost of surgery for the early intervention group will be the same as those who will receive in it on the standard waitlist; therefore, this cost will be removed from the early intervention group. The economic model will evaluate costs and utilities (measured by EQ-5D and WPAI-SHP) and calculate incremental cost-effectiveness ratios (ICERs). The time horizon for this evaluation will be 1 year. No other discounting of costs or utilities is required given this time horizon. Uncertainty around the ICERs will be quantified using bootstrapping. Aim 4 will be analyzed using linear regression models. The best-fit model will provide insight to sub-population of CRS patients who would benefit from early surgical intervention.
Study design
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Surgery wait time (< 8 weeks) | Active comparator | Procedure: Surgery wait timeOutcomes of patients with sinus surgery of less than 8 weeks. |
| Surgery wait time (> 1 year) | Active comparator | Procedure: Surgery wait timeOutcomes of patients with sinus surgery of more than 1 year. |
Who may qualify
- Ages
- 19 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Patients diagnosed with CRS based on 2 major symptoms (congestion, facial pain, nasal obstruction, nasal discharge, decreased sense of smell) and evidence of sino-nasal inflammation on CT scan and nasal endoscopy. Symptoms must also be present for >12 weeks.
Key exclusion criteria (1 listed)
- History of or requiring surgery for a sino-nasal tumour
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Surgery wait timeVCH CRS patients need a waitlist system that promotes wellness and ensures care that focuses on quality - this can be achieved with a prioritized waitlist based on quality of life improvement and decreased healthcare expenditure. | Procedure or surgery | Surgery wait time (< 8 weeks), Surgery wait time (> 1 year) |
Primary outcome
Questionnaire relating to demographics.
Time frame: 30 min to complete questionnaire (once)
Patient demographic information to be completed once after surgery to determine if there is a distinct group of chronic Rhinosinusitis patients who would benefit from early surgical intervention.
Change relating to personal costs over 1 year following surgery.
Time frame: 30 min to complete questionnaire, every two months for 1 year (post-surgery).
Personal costs related to surgical wait times.
Change to the quality of life over 1 year following surgery based on the WPAI-SHP questionnaire.
Time frame: 10 min to complete questionnaire, every two months for 1 year (post-surgery).
The questionnaire WPAI-SHP relates to quality of life after surgery. The Work Productivity and Activity - Specific Health Problem (WPAI:SHP) is a validated instrument to evaluate impairment of daily activities and work productivity associated with a specific health problem (Chronic Rhinosinusitis).
Change to the quality of life over 1 year following surgery based on the SNOT-22 questionnaire.
Time frame: 10 min to complete questionnaire, every two months for 1 year (post-surgery).
The questionnaire SNOT-22 relates to quality of life after surgery. SNOT-22 is a disease-specific health-related quality of life instrument in CRS patients.
Change to the quality of life over 1 year following surgery based on the EQ5-D questionnaire.
Time frame: 10 min to complete questionnaire, every two months for 1 year (post-surgery).
The questionnaire EQ5-D relates to quality of life after surgery. The EQ-5D has 5 questions addressing: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 May 2018.
- Background: PubMed 12838019Chen Y, Dales R, Lin M. The epidemiology of chronic rhinosinusitis in Canadians. Laryngoscope. 2003 Jul;113(7):1199-205. doi: 10.1097/00005537-200307000-00016.
- Background: PubMed 12661586Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Adv Data. 2002 Jun 5;(328):1-32.
- Background: PubMed 7603703Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg. 1995 Jul;113(1):104-9. doi: 10.1016/S0194-59989570152-4.
- BackgroundMickleburgh, R. (2013, January 18). Ministers says BC wait lists too long. The Globe and Mail, Health Care, http://m.theglobeandmail.com/news/british-columbia/minister-says-bc-wait-lists-too-long/article7508904/?service=mobile (accessed on January 30, 2013).
- BackgroundThe economic cost of wait times in Canada. Retrieved from www.cma.ca/multimedia/CMA/Content.../EconomicReport.pdf (accessed on February 2, 2013).
- Background: PubMed 16019691Conner-Spady BL, Sanmugasunderam S, Courtright P, Mildon D, McGurran JJ, Noseworthy TW; Steering Committee of the Western Canada Waiting List Project. The prioritization of patients on waiting lists for cataract surgery: validation of the Western Canada waiting list project cataract priority criteria tool. Ophthalmic Epidemiol. 2005 Apr;12(2):81-90. doi: 10.1080/09286580590932770.
- Background: PubMed 15609803Conner-Spady B, Estey A, Arnett G, Ness K, McGurran J, Bear R, Noseworthy T; Steering Committee of the Western Canada Waiting List Project. Prioritization of patients on waiting lists for hip and knee replacement: validation of a priority criteria tool. Int J Technol Assess Health Care. 2004 Fall;20(4):509-15. doi: 10.1017/s0266462304001436.
- Background: PubMed 12391927Hadorn DC; Steering Committee of the Western Canada Waiting List Project. Developing priority criteria for magnetic resonance imaging: results from the Western Canada Waiting List Project. Can Assoc Radiol J. 2002 Oct;53(4):210-8.
- Background: PubMed 12558699Noseworthy TW, McGurran JJ, Hadorn DC; Steering Committee of the Western Canada Waiting List Project. Waiting for scheduled services in Canada: development of priority-setting scoring systems. J Eval Clin Pract. 2003 Feb;9(1):23-31. doi: 10.1046/j.1365-2753.2003.00377.x.
- Background: PubMed 11980781Ben-Shlomo Y, Kuh D. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol. 2002 Apr;31(2):285-93. No abstract available.
- BackgroundWestern Canada Waiting List Investigators .(2013). Retrieved on February 2, 2013 from http://www.wcwl.ca/.
- Background: PubMed 11889389Damm M, Quante G, Jungehuelsing M, Stennert E. Impact of functional endoscopic sinus surgery on symptoms and quality of life in chronic rhinosinusitis. Laryngoscope. 2002 Feb;112(2):310-5. doi: 10.1097/00005537-200202000-00020.
Related trials for Rhinosinusitis
Recruiting
Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Enrolling by invitationObservational study
Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)
Anosmia, Chronic Obstructive Pulmonary Disease
Not yet recruitingPhase 3
A Study to Evaluate the Efficacy and Safety of MG-K10 in Adults With Chronic Rhinosinusitis With Nasal Polyps
Chronic Rhinosinusitis With Nasal Polyps
Active, not recruitingPhase 3
Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Active, not recruitingPhase 2
Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical Study
Chronic Rhinosinusitis With Nasal Polyps
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Arif Janjua, MD principal investigator
UBC
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Early Phase 1 study testing Surgery wait time in people with Rhinosinusitis, run by University of British Columbia at 2 sites in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 8 May 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Andrew Thamboo, MD (650-308-6376, andrew.thamboo@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Questionnaire relating to demographics. (time frame: 30 min to complete questionnaire (once)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02636790, which also lists 19 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2018.